Results 261 to 270 of about 2,361,739 (390)
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell marker in several malignancies. We established a novel epithelial cell line from rectal adenocarcinoma with unique overexpression of this enzyme. Genetic attenuation of ALDH1A1 led to increased invasive capacity and metastatic potential, the inhibition of proliferation activity, and ultimately ...
Martina Poturnajova +25 more
wiley +1 more source
Addressing communication dynamics in traditional medicine use disclosure to physicians. [PDF]
Gumede L.
europepmc +1 more source
Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra +6 more
wiley +1 more source
Empirically assessing corporate adaptation and resilience disclosure using AI. [PDF]
Spacey Martín R +3 more
europepmc +1 more source
Audit data analytics of unregulated voluntary disclosures and auditing expectations gap
Amir Michael, Rob Dixon
openalex +2 more sources
Tumors contain diverse cellular states whose behavior is shaped by context‐dependent gene coordination. By comparing gene–gene relationships across biological contexts, we identify adaptive transcriptional modules that reorganize into distinct vulnerability axes.
Brian Nelson +9 more
wiley +1 more source
Corrigendum to "When Stigma, Disclosure, and Access to Care Collide: An Ethical Reflection of mpox Vaccination Outreach". [PDF]
europepmc +1 more source

